<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Srishyla D</submitter><funding>FIC NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><funding>NINDS</funding><pagination>myac013</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8973400</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>60(4)</volume><pubmed_abstract>Cryptococcal antigen (CrAg) screening and pre-emptive antifungal therapy for people with CD4 cell counts &lt;100 cells/μl are recommended by the World Health Organization and several national HIV guidelines. We sought to evaluate CrAg screening program implementation across Uganda, in relation to health center level and distance from the capital. We conducted a cross-sectional study of 22 health centers across southern Uganda from April to June 2019. We reviewed laboratory records regarding number of CD4 cell count tests performed, proportion of outpatients with CD4 counts &lt;200 cells/μl, and number of CrAg screening tests performed. We administered surveys to health center staff to understand barriers to advanced HIV care. We observed no significant difference in health center level and perfo</pubmed_abstract><journal>Medical mycology</journal><pubmed_title>Determinants of cryptococcal antigen (CrAg) screening uptake in Kampala, Uganda: An assessment of health center characteristics.</pubmed_title><pmcid>PMC8973400</pmcid><funding_grant_id>D43TW009345</funding_grant_id><funding_grant_id>U01 AI125003</funding_grant_id><funding_grant_id>K23 AI138851</funding_grant_id><funding_grant_id>T32AI055433</funding_grant_id><funding_grant_id>K23AI138851</funding_grant_id><funding_grant_id>D43 TW009345</funding_grant_id><funding_grant_id>U01AI125003</funding_grant_id><pubmed_authors>Meya DB</pubmed_authors><pubmed_authors>Jjunju S</pubmed_authors><pubmed_authors>Srishyla D</pubmed_authors><pubmed_authors>Saemisch G</pubmed_authors><pubmed_authors>Kagimu E</pubmed_authors><pubmed_authors>Nalintya E</pubmed_authors><pubmed_authors>Boulware DR</pubmed_authors><pubmed_authors>Turya F</pubmed_authors><pubmed_authors>Rutakingirwa MK</pubmed_authors><pubmed_authors>Skipper CP</pubmed_authors><pubmed_authors>Rajasingham R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Determinants of cryptococcal antigen (CrAg) screening uptake in Kampala, Uganda: An assessment of health center characteristics.</name><description>Cryptococcal antigen (CrAg) screening and pre-emptive antifungal therapy for people with CD4 cell counts &lt;100 cells/μl are recommended by the World Health Organization and several national HIV guidelines. We sought to evaluate CrAg screening program implementation across Uganda, in relation to health center level and distance from the capital. We conducted a cross-sectional study of 22 health centers across southern Uganda from April to June 2019. We reviewed laboratory records regarding number of CD4 cell count tests performed, proportion of outpatients with CD4 counts &lt;200 cells/μl, and number of CrAg screening tests performed. We administered surveys to health center staff to understand barriers to advanced HIV care. We observed no significant difference in health center level and perfo</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2026-06-04T04:59:40.371Z</modification><creation>2025-04-19T13:33:17.621Z</creation></dates><accession>S-EPMC8973400</accession><cross_references><pubmed>35353190</pubmed><doi>10.1093/mmy/myac013</doi></cross_references></HashMap>